ArticleFrontiers in pharmacology2026

Anifrolumab for rituximab-induced SCLE and cryoglobulinemic vasculitis in primary Sjögren's disease: a case report.

I Magi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.